Citation

Jakšić D, Šegvić Klarić M, Rimac H, Kerep R, Piantanida I. Int. J. Mol. Sci. 2023; 24(5): e4485.

Copyright

(Copyright © 2023, Molecular Diversity Preservation International)

DOI

10.3390/ijms24054485

PMID

36901918

PMCID

PMC10003537

Abstract

This study demonstrates that sterigmatocystin (STC) interacts non-covalently with various cyclodextrins (CDs), showing the highest binding affinity for sugammadex (a γ-CD derivative) and γ-CD, and an almost order of magnitude lower affinity for β-CD. This difference in affinity was studied using molecular modelling and fluorescence spectroscopy, which demonstrated a better insertion of STC into larger CDs. In parallel, we showed that STC binds to human serum albumin (HSA) (a blood protein known for its role as a transporter of small molecules) with an almost two order of magnitude lower affinity compared to sugammadex and γ-CD. Competitive fluorescence experiments clearly demonstrated an efficient displacement of STC from the STC-HSA complex by cyclodextrins. These results are a proof-of-concept that CDs can be used to complex STC and related mycotoxins. Similarly, as sugammadex extracts neuromuscular relaxants (e.g., rocuronium and vecuronium) from blood and blocks their bioactivity, it could also be used as first aid upon acute intoxication to encapsulate a larger part of the STC mycotoxin from serum albumin.

Language: en

Keywords

circular dichroism; competitive binding; cyclodextrin; fluorescence; mycotoxin sterigmatocystin